The biomarker CD3+/CD4-/CD8- identifies a unique subset of T lymphocytes that express the CD3 surface protein but lack both CD4 and CD8 co-receptors. These cells are often referred to as double-negative T cells (DN T cells) due to their absence of CD4 and CD8 expression. DN T cells represent a small fraction of the total T cell population in peripheral blood, typically accounting for less than 5% of T cells. Despite their rarity, these cells play important roles in immune regulation and have been implicated in various autoimmune diseases, transplant rejection, and cancer immunology. DN T cells can exhibit both immunosuppressive and pro-inflammatory functions, depending on the context. They are capable of producing cytokines and can have cytotoxic activity. The CD3+/CD4-/CD8- phenotype is typically assessed using flow cytometry, which allows for precise identification and quantification of this cell population. Alterations in the frequency or function of DN T cells may serve as indicators of immune dysregulation or specific disease states.f
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.